Menu

• Ask a Health Expert about RETINAL PIGMENTATION
• Post Your Side Effect related to RETINAL PIGMENTATION
• RETINAL PIGMENTATION and FDA Warnings
• RETINAL PIGMENTATION in Patients Wiki
• Report RETINAL PIGMENTATION in Drug Side Effect Survey

RETINAL PIGMENTATION side effect

What is RETINAL PIGMENTATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Lamictal Side Effects Report #5392402-4
Physician from IRELAND reported LAMICTAL problem on July 17, 2007. Female patient, 45 years of age, weighting 220.5 lb, was diagnosed with depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: retinal pigmentation, vision blurred, visual acuity reduced, . LAMICTAL dosage: 100MG TWICE PER DAY. During the same period patient was treated with CYMBALTA. Patient recovered.

Lamictal Side Effects Report #5392402-4
LAMICTAL problem was reported by a Physician from IRELAND on July 17, 2007. Female patient, 45 years of age, weighting 220.5 lb, was diagnosed with depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: retinal pigmentation, vision blurred, visual acuity reduced, . LAMICTAL dosage: 100MG TWICE PER DAY. During the same period patient was treated with CYMBALTA. Patient recovered.

Cymbalta Side Effects Report #5367930-8
Physician from IRELAND reported CYMBALTA problem on June 18, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: retinal pigmentation, visual disturbance, . CYMBALTA dosage: 120 MG, UNK. During the same period patient was treated with EFFEXOR, LAMICTAL. Patient recovered.

Cymbalta Side Effects Report #5368451-9
CYMBALTA problem was reported by a Physician from IRELAND on June 18, 2007. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: retinal pigmentation, visual disturbance, . CYMBALTA dosage: 120 MG, UNK. During the same period patient was treated with EFFEXOR, LAMICTAL. Patient recovered.


Mefloquine Side Effects Report #5388628-6
Consumer or non-health professional from reported MEFLOQUINE problem on July 13, 2007. Male patient, 43 years of age, was diagnosed with malaria prophylaxis and was treated with MEFLOQUINE. After drug was administered, patient experienced the following problems/side effects: maculopathy, retinal pigmentation, . MEFLOQUINE dosage: unknown. Patient recovered.

Mefloquine Side Effects Report #5388628-6
MEFLOQUINE problem was reported by a Consumer or non-health professional from on July 13, 2007. Male patient, 43 years of age, was diagnosed with malaria prophylaxis and was treated with MEFLOQUINE. After drug was administered, patient experienced the following problems/side effects: maculopathy, retinal pigmentation, . MEFLOQUINE dosage: unknown. Patient recovered.

Xalatan Side Effects Report #5335845-7
Pharmacist from UNITED STATES reported XALATAN problem on Aug 17, 2006. Female patient, 59 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye irritation, retinal pigmentation, . XALATAN dosage: unknown. During the same period patient was treated with SYNTHROID, AMBIEN. Patient recovered.

Cymbalta Side Effects Report #5478632-1
CYMBALTA problem was reported by a Physician from IRELAND on Sept 25, 2007. Female patient was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: myopia, retinal pigmentation, visual disturbance, . CYMBALTA dosage: 60 MG, 2/D. During the same period patient was treated with EFFEXOR, LAMICTAL. Patient recovered.

Exjade Side Effects Report #5321989-2
Physician from UNITED KINGDOM reported EXJADE problem on May 03, 2007. Female patient, child 12 years of age, weighting 79.37 lb, was diagnosed with blood iron increased and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: heterophoria, retinal pigmentation, retinopathy, visual disturbance, . EXJADE dosage: 750 MG, QD. Patient recovered.